Cardiff Oncology (CRDF) Other Non-Current Assets (2016 - 2025)
Historic Other Non-Current Assets for Cardiff Oncology (CRDF) over the last 16 years, with Q3 2025 value amounting to $549000.0.
- Cardiff Oncology's Other Non-Current Assets fell 5666.93% to $549000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $549000.0, marking a year-over-year decrease of 5666.93%. This contributed to the annual value of $69000.0 for FY2024, which is 9460.52% down from last year.
- Per Cardiff Oncology's latest filing, its Other Non-Current Assets stood at $549000.0 for Q3 2025, which was down 5666.93% from $401000.0 recorded in Q2 2025.
- In the past 5 years, Cardiff Oncology's Other Non-Current Assets ranged from a high of $1.4 million in Q2 2023 and a low of $69000.0 during Q4 2024
- In the last 5 years, Cardiff Oncology's Other Non-Current Assets had a median value of $401000.0 in 2025 and averaged $701736.8.
- Per our database at Business Quant, Cardiff Oncology's Other Non-Current Assets skyrocketed by 65380.43% in 2023 and then crashed by 9460.52% in 2024.
- Cardiff Oncology's Other Non-Current Assets (Quarter) stood at $239000.0 in 2021, then surged by 480.33% to $1.4 million in 2022, then decreased by 7.79% to $1.3 million in 2023, then plummeted by 94.61% to $69000.0 in 2024, then soared by 695.65% to $549000.0 in 2025.
- Its Other Non-Current Assets was $549000.0 in Q3 2025, compared to $401000.0 in Q2 2025 and $257000.0 in Q1 2025.